181 - Final Long-Term Results from the Defifrance Registry Study: Efficacy and Safety of Defibrotide (DF) for the Treatment of Severe/Very Severe Veno-Occlusive Disease/ Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Cell Transplantation (HCT)

Mohamad Mohty,Didier Blaise,Régis Peffault De Latour,Myriam Labopin,Marie Detrait,Anne Huynh,Hélène Labussière-Wallet,Thierry Lamy,Delphine Lebon,Sébastien Maury,Cecile Renard,Kobby Asubonteng,Floriane Delaval,Ibrahim Yakoub-Agha,Jean-Hugues Dalle

doi:10.1016/s2666-6367(22)00342-6

181 - Final Long-Term Results from the Defifrance Registry Study: Efficacy and Safety of Defibrotide (DF) for the Treatment of Severe/Very Severe Veno-Occlusive Disease/ Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Cell Transplantation (HCT)

Mohamad Mohty, Didier Blaise + Show 13 more

Open Access

https://doi.org/10.1016/s2666-6367(22)00342-6

Copy DOI

Journal: Biology of Blood and Marrow Transplantation	Publication Date: Mar 1, 2022
License type: cc-by-nc-nd

#Veno-Occlusive Disease / Sinusoidal Obstruction Syndrome #Safety Of Defibrotide + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

181 - Final Long-Term Results from the Defifrance Registry Study: Efficacy and Safety of Defibrotide (DF) for the Treatment of Severe/Very Severe Veno-Occlusive Disease/ Sinusoidal Obstruction Syndrome (VOD/SOS) after Hematopoietic Cell Transplantation (HCT)

Full Text